Obesity: Drugs
2026-06-14 · Department of Health and Social Care · HL922 · Official question
Question
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 10 June (HL543), whether those categories of patients now eligible to receive semaglutide by injection will also be eligible for orforglipron tablets on the same basis.
Answer
Orforglipron does not yet have a marketing authorisation from the Medicines and Healthcare products Regulatory Agency, so it cannot currently be marketed in the United Kingdom. Any future licence would set out the condition it can be used for, and the rec...